Bansk Group announced it has closed a continuation fund transaction to expand and extend its ownership partnership with Arcadia Consumer Healthcare, a fast-growing platform in over-the-counter medicines and premium vitamins and nutritional supplements.
The continuation vehicle was co-led by Coller Capital and Ares Secondaries Funds, with additional backing from investment funds managed by BlackRock, Churchill, Dextra Partners, and Future Standard, among others. Bansk said the transaction provides liquidity to existing investors while also allowing others to roll their stakes into the new structure to support Arcadia’s next phase of growth.
Arcadia’s portfolio includes CloSYS, Colace, Senokot, and Nizoral, alongside a broader group of consumer health brands such as Naturelo, Betadine, Kaopectate, FungiNail, SlowMag, Safetussin, and OptiNail. Bansk first invested in Arcadia in 2021, and the firm said the company has since pursued multiple organic growth initiatives and completed two major acquisitions.
How the funds will be used: Bansk said the new capital positions Arcadia to accelerate both organic expansion and further acquisitions as it looks to broaden its product lineup and deepen its footprint across retail and e-commerce channels nationwide. Arcadia products are sold through major retailers and online, including direct-to-consumer channels.
Support: Evercore served as financial advisor to Bansk, and Kirkland & Ellis served as legal counsel.
KEY QUOTES:
“Arcadia’s trajectory over the past four years reflects Bansk’s strategy in action – partnering with great consumer businesses and helping them scale with discipline, innovation, and a deep commitment to the end consumer.”“The Company enters this next chapter with exceptional momentum and a proven platform for growth. We look forward to continuing our partnership with CEO Mike DeBiasi and the entire Arcadia team.”
Chris Kelly, Senior Partner, Bansk
“We are very proud of what we’ve accomplished with the Arcadia team in realizing our shared vision to create a leading consumer healthcare platform recognized for innovation and operational excellence.”“We were pleased to deliver an outcome that offered our existing investors a liquidity option, and the continued support from several of our existing investors is a testament to their continued confidence in Arcadia’s growth potential.”
Bart Becht, Senior Partner and Chairman, Bansk
“With Bansk’s support, Arcadia has transformed into a dynamic platform for innovation and growth in consumer healthcare.”“Our mission is clear: to build a differentiated portfolio of health and wellness brands that help consumers achieve the harmony of feeling and looking good.”“Bansk has been instrumental in elevating and expanding our portfolio of brands, and we are confident this partnership will enable us to deliver even greater value to consumers and drive sustained growth across our business.”
Mike DeBiasi, Chief Executive Officer, Arcadia Consumer Healthcare
